Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -134 | -3,350 | -2,655 | -2,432 | -645 |
| Depreciation Amortization | 0 | 230 | 234 | 216 | 108 |
| Accounts receivable | -25 | -4 | -5 | -89 | -86 |
| Accounts payable and accrued liabilities | 10 | 5 | 10 | 33 | -5 |
| Other Working Capital | 82 | 150 | 7 | 2 | -44 |
| Other Operating Activity | 30 | 2,099 | 1,840 | 1,728 | 169 |
| Operating Cash Flow | $-37 | $-870 | $-570 | $-542 | $-502 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 20 | -1 | -1 | -1 |
| Other Investing Activity | 27 | 20 | 0 | 0 | 0 |
| Investing Cash Flow | $27 | $40 | $-1 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 728 | N/A |
| Debt Issued | 15 | 753 | 753 | N/A | 450 |
| Debt Repayment | N/A | -20 | -20 | -28 | -14 |
| Common Stock Issued | N/A | 88 | 88 | 88 | 88 |
| Other Financing Activity | 0 | -1 | 0 | -14 | 0 |
| Financing Cash Flow | $15 | $820 | $821 | $774 | $524 |
| Beginning Cash Position | 14 | 20 | 21 | 21 | 21 |
| End Cash Position | 6 | 10 | 15 | 15 | 42 |
| Net Cash Flow | $-8 | $-10 | $-6 | $-6 | $21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37 | -870 | -570 | -542 | -502 |
| Capital Expenditure | N/A | -1 | -1 | -1 | -1 |
| Free Cash Flow | -37 | -871 | -571 | -543 | -504 |